DRIO DarioHealth Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: DRIO

Price (delayed)

$7.27

Market cap

$53.16M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.88

Enterprise value

$70M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 21

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software ...

Highlights
DRIO's EPS is up by 21% year-on-year and by 12% since the previous quarter
The company's net income rose by 9% YoY and by 2.3% QoQ
The quick ratio has increased by 48% YoY but it has decreased by 21% QoQ
The revenue has declined by 24% year-on-year and by 5% since the previous quarter
DarioHealth's gross profit has decreased by 19% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.mydario.com
Peers: CSBR QURE AUPH

Key stats

What are the main financial stats of DRIO

DRIO stock price

How has the DarioHealth stock price performed over time
Intraday
-4.97%
1 week
-3.32%
1 month
-2.42%
1 year
-47.77%
YTD
-36.12%
QTD
-9.35%

Financial performance

How have DarioHealth's revenue and profit performed over time
Revenue
$21.19M
Gross profit
$11.98M
Operating income
-$34.56M
Net income
-$40.74M
Gross margin
56.5%
Net margin
-192.2%
DarioHealth's operating income has increased by 30% YoY and by 6% from the previous quarter
The revenue has declined by 24% year-on-year and by 5% since the previous quarter
The net margin has contracted by 20% YoY and by 3% from the previous quarter
DarioHealth's gross profit has decreased by 19% YoY and by 5% from the previous quarter

Price vs fundamentals

How does DRIO's price correlate with its fundamentals

Growth

What is DarioHealth's growth rate over time

Valuation

What is DarioHealth stock price valuation
P/E
N/A
P/B
0.85
P/S
2.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.3
DRIO's EPS is up by 21% year-on-year and by 12% since the previous quarter
The P/B is 18% lower than the 5-year quarterly average of 1.1 but 13% higher than the last 4 quarters average of 0.8
DRIO's equity is down by 15% year-on-year and by 8% since the previous quarter
DRIO's P/S is 52% below its 5-year quarterly average of 5.0 but 19% above its last 4 quarters average of 2.0
The revenue has declined by 24% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is DarioHealth business performance
The ROIC has grown by 34% YoY and by 13% from the previous quarter
DRIO's ROA is down by 30% YoY but it is up by 7% QoQ
DarioHealth's return on equity has decreased by 23% YoY but it has increased by 6% QoQ
DRIO's ROS is down by 10% year-on-year

Dividends

What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRIO.

Financial health

How did DarioHealth financials performed over time
The total assets is 153% greater than the total liabilities
DarioHealth's current ratio has soared by 53% YoY but it has decreased by 18% from the previous quarter
The quick ratio has increased by 48% YoY but it has decreased by 21% QoQ
The debt is 49% less than the equity
The company's debt to equity rose by 24% YoY and by 9% QoQ
DRIO's equity is down by 15% year-on-year and by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.